Abstract
Objective
To investigate the relationship between metabolic syndrome and hyperuricemia.
Methods
A total of 2374 subjects who received health examination in our hospital from Jan. 2004 to Dec. 2006 were enrolled in our study. Hyperuricemia is defined as ≥ 7 mg/dl (in men) or ≥6.0 mg/dl (in women). Metabolic syndrome was defined using AHA/NHLBI (American Heart Association/National Heart, Lung, and Blood Institute) criteria.
Results
(1) The overall prevalence of hyperuricemia was 13.10%. The condition was more common in men than in women (19.07% vs 3.42%). (2) Among men, uric acid concentration is statistically significantly positively correlated with waist circumference, blood pressure, and triglyceride. Uric acid is negatively correlated with serum high-density lipoprotein-cholesterol (HDL-C). Uric acid concentration is most strongly correlated with serum triglyceride (r=0.379) and waist circumference (r=0.297). Among women, statistically significant positive correlations were noted for the serum uric acid concentrations with waist circumference, triglyceride and fasting plasma glucose. Serum triglyceride (r=0.329) and waist circumference (r=0.234) are most strongly correlated with uric acid concentrations. (3) Men with hyperuricemia had a 1.634-fold increased risk of metabolic syndrome as compared with those without hyperuricemia [odds ratio (OR)=1.634, P=0.000]. Women with hyperuricemia had a 1.626-fold increased risk of metabolic syndrome (OR=1.626, P=0.000) as compared with those without hyperuricemia.
Conclusion
Hyperuricemia is prevalent among Chinese population. Additionally, serum uric acid is positively associated with metabolic syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alderman, M., Redfern, J.S., 2004. Serum uric acid: a cardiovascular risk factor? Ther. Umsch., 61(9):547–552. [doi: 10.1024/0040-5930.61.9.547]
Becker, M.A., Jolly, M., 2006. Hyperuricemia and associated disease. Rheum. Dis. Clin. North Am., 32(2):275–287. [doi: 10.1016/j.rdc.2006.02.005]
Bedir, A., Topbas, M., Tanyeri, F., Alvur, M., Arik, N., 2003. Leptin might be a regulator of serum uric acid concentration in human. Jpn. Heart J., 44(4):527–536. [doi: 10.1536/jhj.44.527]
Bo, S., Cavallo-Perin, P., Gentile, L., Repetti, E., Pagano, G., 2001. Low HDL cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients. Diabetes Metab., 27(1):31–35.
Bonora, E., Targher, G., Zenere, M.B., Saggiani, F., Cacciatori, V., Tosi, F., Travia, D., Zenti, M.G., Branzi, P., Santi, L., et al., 1996. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int. J. Obes. Relat. Metab. Disord., 20(11):975–980.
Bosello, O., Zamboni, M., 2000. Visceral obesity and metabolic syndrome. Obes. Rev., 1(1):47–56. [doi: 10.1046/j.1467-789x.2000.00008.x]
Conen, D., Wietlisbach, V., Bovet, P., Shamlaye, C., Riesen, W., Paccaud, F., Burnier, M., 2004. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health, 4(1):9. [doi: 10.1186/1471-2458-4-9]
Feig, D.I., Johnson, R.J., 2003. Hyperuricemia in childhood primary hypertension. Hypertension, 42(3):247–252. [doi: 10.1161/01.HYP.0000085858.66548.59]
Fruehwald-Schultes, B., Peters, A., Kern, W., Beyer, J., Pfutzner, A., 1999. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism, 48(6): 677–680. [doi: 10.1016/S0026-0495(99)90163-4]
Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C.Jr, et al., 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17): 2735–2752. [doi: 10.1161/CIRCULATIONAHA.105.169404]
Himmelmann, A., Kjeldsen, S.E., Hedner, T., 2003. Recent hypertension guidelines: JNC-7 and ESH/ESC. Blood Press., 12(4):196–197. [doi: 10.1080/08037050310015854]
Hochberg, M.C., Smolen, J.S., Weinblatt, M.E., Weisman, M.H., 2003. Rheumatology, 3rd Ed. Mosby, New York.
Krishnan, E., Kwoh, C.K., Schumacher, H.R., Kuller, L., 2007. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension, 49(2): 298–303. [doi: 10.1161/01.HYP.0000254480.64564.b6]
Leyva, F., Wingrove, C.S., Godsland, I.F., Stevenson, J.C., 1998. The glycolytic pathway to coronary heart disease: a hypothesis. Metabolism, 47(6):657–662. [doi. 10.1016/S0026-0495(98)90026-9]
Matsuura, F., Yamashita, S., Nakamura, T., Nishida, M., Nozaki, S., Funahashi, T., Matsuzawa, Y., 1998. Effect of visceral fat accumulation on uric acid metabolismin male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism, 47(8):929–933. [doi: 10.1016/S0026-0495(98)90346-8]
Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K.R., Short, R.A., Glushakova, O., Ouyang, X., Feig, D.I., Block, E.R., Herrera-Acosta, J., et al., 2006. A causal role for uric acid in fructose-induced metabolic syndrome. Am. J. Physiol. Renal Physiol., 290(3):F625–F631. [doi: 10.1152/ajprenal.00140.2005]
Nakanishi, N., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K., Tatara, K., 2003. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur. J. Epidemiol., 18(6):523–530. [doi: 10.1023/A:1024600905574]
Rho, Y.H., Choi, S.J., Lee, Y.H., Ji, J.D., Choi, K.M., Baik, S.H., Chung, S.H., Kim, C.G., Choe, J.Y., Lee, S.W., et al., 2005. The prevalence of metabolic syndrome in patients with gout: a multicenter study. J. Korean Med. Sci., 20(6):1029–1033.
Schachter, M., 2005. Uric acid and hypertension. Curr. Pharm. Des., 11(32):4139–4143. [doi: 10.2174/138161205774913246]
Schmidt, M.I., Watson, R.L., Duncan, B.B., Metcalf, P., Brancati, F.L., Sharrett, A.R., Davis, C.E., Heiss, G., 1996. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metabolism, 45(6):699–706. [doi: 10.1016/S0026-0495(96)90134-1]
Sumino, H., Ichikawa, S., Kanda, T., Nakamura, T., Sakamaki, T., 1999. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet, 354(9179):650. [doi: 10.1016/S0140-6736(99)92381-4]
Tai, E.S., Emmanuel, S.C., Chew, S.K., Tan, B.Y., Tan, C.E., 1999. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia. Diabetes, 48(5):1088–1092. [doi: 10.2337/diabetes.48.5.1088]
Yoo, T.W., Sung, K.C., Shin, H.S., Kim, B.J., Kim, B.S., Kang, J.H., Lee, M.H., Park, J.R., Kim, H., Rhee, E.J., et al., 2005. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ. J., 69(8):928–933. [doi: 10.1253/circj.69.928]
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Health Promotion Center in Sir Run Run Shaw Hospital, the Affiliated Hospital of Zhejiang University, China
Rights and permissions
About this article
Cite this article
Chen, Ly., Zhu, Wh., Chen, Zw. et al. Relationship between hyperuricemia and metabolic syndrome. J. Zhejiang Univ. - Sci. B 8, 593–598 (2007). https://doi.org/10.1631/jzus.2007.B0593
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1631/jzus.2007.B0593